• Subject is a postmenopausal female at least 1-year post menses and at least 65 years of age.

• Subject presents with a low-energy index fragility hip fracture in one hip and will undergo surgical repair of the fractured hip.

• Subject has at least one of the following additional risk factors for a secondary hip fracture (as determined by subject or legally authorized representative (LAR) interview or medical record review):

‣ Documented falls assessment indicating subject is at moderate or high risk of falls

⁃ Falls history (2 or more falls in the previous 12 months)

⁃ History of vertigo, dizziness, or postural hypotension

⁃ Documented T-score \< -2.5 at the hip

⁃ Taking more than 3 daily prescription medications

⁃ Visual impairment as confirmed by one of the following:

• Subject reports difficulty seeing

∙ Lack of depth perception or vision loss in one eye

∙ Macular degeneration

∙ Cataracts

⁃ Prior non-hip fragility fracture

⁃ Cognitive frailty as assessed by SPMSQ (mild or moderate cognitive impairment) or delirium

⁃ Parkinson's disease stage 3 or 4

⁃ 10-year hip fracture probability \>15% using the FRAX® Fracture Risk Assessment Tool of the clinical site country

• Subject is expected to be ambulatory after the hip fracture repair procedure.

• Informed consent is provided by the subject or the subject's LAR.

• The subject's willingness, ability, and commitment to participate in screening, treatment, and all follow-up evaluations for the full duration of the study has been documented.